Bioventus Inc
General ticker "BVS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $746.9M
Bioventus Inc follows the US Stock Market performance with the rate: 51.6%.
Estimated limits based on current volatility of 2.3%: low 10.41$, high 10.90$
Factors to consider:
- Current price 152.6% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.60$, 4.65$]
- 2023-12-31 to 2024-12-30 estimated range: [1.58$, 4.22$]
Short-term BVS quotes
Long-term BVS plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $321.16MM | $436.57MM | $512.12MM |
| Operating Expenses | $299.92MM | $424.51MM | $763.16MM |
| Operating Income | $21.24MM | $12.06MM | $-251.05MM |
| Non-Operating Income | $-5.32MM | $-4.44MM | $-12.85MM |
| Interest Expense | $9.75MM | $1.11MM | $25.80MM |
| R&D Expense | $11.20MM | $19.04MM | $25.94MM |
| Income(Loss) | $15.91MM | $7.62MM | $-263.90MM |
| Taxes | $1.19MM | $-1.97MM | $-50.51MM |
| Profit(Loss) | $14.72MM | $9.59MM | $-213.39MM |
| Stockholders Equity | $142.24MM | $458.92MM | $316.58MM |
| Inventory | $29.12MM | $61.69MM | $85.41MM |
| Assets | $494.47MM | $1,225.86MM | $1,372.65MM |
| Operating Cash Flow | $71.80MM | $22.99MM | $-13.54MM |
| Capital expenditure | $20.67MM | $7.37MM | $11.52MM |
| Investing Cash Flow | $-20.50MM | $-283.76MM | $-116.44MM |
| Financing Cash Flow | $-29.57MM | $273.37MM | $62.08MM |
| Earnings Per Share* | $0.08 | $0.16 | $-3.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.